cause – Page 11 – Communicable Diseases Research

[Comparative study of patients hospitalized for SARS-CoV-2 infection in two consecutive waves in Tunisia]

Article

Published on 2022-08-182022-11-16
Journal: Médecine tropicale et santé internationale [Category] SARS, 변종,

The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

Research

Published on 2022-08-172022-10-05
Journal: Communications Biology [Category] SARS, 치료제,

[키워드] ACE2 acute respiratory syndrome angiotensin-converting enzyme-2 attenuate cause coronavirus COVID-19 COVID-19 patients cytopathic effects Deprivation Evidence exacerbated expressed expressing Fatty liver full-length Glycolysis hACE2 hepatic dysfunction hepatocyte hepatocytes Human humanized hyperglycemia immune response include increase Infection infection with SARS-CoV-2 Inflammation inhibition Injury metformin methionine mice mitochondrial Multi-organ damage Patient promote pseudotyped viral particles pseudovirus RBD Receptor binding domain reduce renin-angiotensin system SARS-CoV-2 steatosis susceptibility susceptible therapeutic option Toxicity type 2 diabete viral particle
[DOI] 10.1038/s42003-022-03789-9 [Article Type] Research

Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission

Article

Published on 2022-08-172022-11-15
Journal: Frontiers in Immunology [Category] SARS, 진단,

[키워드] accumulating acquisition acute respiratory disease Administered aerosol antibody Antibody Response asymptomatic infection cause Community consequence Contact COVID COVID-19 demonstrated disease droplet explain helping humans immune system Immunoglobulin immunoglobulin A induce Infection initial intranasally limit lung mice Mild mucosal mucosal immune mucosal immunity mucosal secretion naïve subjects nasal fluid nasal passage Prevent protective immune response recall repeated response resulting Saliva SARS-CoV-2 SARS-COV-2 infection secretion secretory IgA SIgA Spread subjects suppress tonsil Transmission upper respiratory upper respiratory tract Vaccine virus while
[DOI] 10.3389/fimmu.2022.957107 PMC 바로가기

Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples

인간 샘플에서 SARS-CoV-2에 대한 항체 검출을 위한 3가지 ELISA의 진단 성능

Article

Published on 2022-08-162022-09-11
Journal: The Scientific World Journal [Category] SARS, 진단, 치료기술, 치료법,

[키워드] Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus antibody production Antibody responses Antigen antigens approach cause Cohort coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 detection determine Diagnosis disease ELISA ELISAs evaluated fraction Human IgG immunoassay immunoassays Immunoglobulin Immunoglobulin G immunological indicated Infection N protein nucleocapsid patients performance Protein RBD Receptor binding domain respiratory Sample SARS-CoV-2 SARS-CoV-2 infections sensitivities sensitivity serological test Serological tests severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Specificities specificity Spike protein subject the antibody response the N protein Transmission
[DOI] 10.1155/2022/7754329 PMC 바로가기 [Article Type] Article

New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19

항균제에 대한 새로운 관점: 코로나19 치료를 위한 몰누피라비르 및 니르마트렐비르/리토나비르

Article

Published on 2022-08-162022-09-11
Journal: Antimicrobial Agents and Chemotherapy [Category] COVID19(2023년), SARS, 변종, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition adjusted relative risk antimicrobial Antiviral cause childbearing potential children Complication Contraception coronavirus disease Coronavirus-2 COVID-19 cytochrome P450 Cytochrome P450 enzymes death drug Drug administration Drug-to-drug interaction Each Emergency use authorization food hospitalizations in vitro inhibit limit management medication metabolism Mild mild to moderate moderate molnupiravir morbidity and mortality Mutation New Nirmatrelvir Nirmatrelvir/ritonavir nonspecific outcome pandemic Patient polymerase polyprotein pregnant protease proteolytic cleavage reduction Relative risk Replication Respiratory disease risk Ritonavir SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 significantly target tested Toxicity Treatment treatment regimen U.S. Food and Drug Administration variant viral replication virus virus production
[DOI] 10.1128/aac.02404-21 PMC 바로가기 [Article Type] Article

Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine

BNT162b2 백신의 추가 접종 후 오미크론 변이체에 대한 보호 항체 및 T 세포 반응

Article

Published on 2022-08-162022-09-11
Journal: Cell Reports Medicine [Category] SARS, 변종, 진단, 치료기술,

[키워드] ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse effects angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antibody antibody levels blocking antibodies BNT162b2 BNT162b2 vaccine booster dose cause CD4 CD8 coronavirus detectable domain dose dynamics of the immune response ENhance immune Immune escape immune response increase Interaction less longitudinal analysis majority memory mRNA mRNA vaccine Mutation of BNT162b2 omicron Omicron variant protective antibodies Protective antibody Protein RBD RBD-ACE2 receptor respiratory SARS-CoV-2 SARS-CoV-2 mRNA vaccine second dose serum severe acute respiratory syndrome Coronavirus Spike protein spike RBD-ACE2 inhibition. T cell T cell response T cell responses T cells vaccinated individual vaccinated individuals Vaccine variant variant spike wild-type
[DOI] 10.1016/j.xcrm.2022.100716 PMC 바로가기 [Article Type] Article

Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21

Randomized Controlled Trial

Published on 2022-08-152022-10-05
Journal: Trials [Category] SARS, 임상,

[키워드] Admission breathlessness cause chest pain Contact Controlled clinical trial COVID COVID-19 COVID-19 infection diagnosis of COVID-19 discharged Dyspnoea early treatment Effect Ethical approval ethics committee Exercise capacity fatigue frailty group Health Health status healthcare professionals hospital hospitalisation hospitalised Infection Intervention Long Long COVID National Health Service NHS participant Patient personalised physical physical activity Pragmatic prevention Primary outcome problem Quality of life questionnaire randomisation randomised randomised controlled trial REC recruitment Registered rehabilitation resistance resistance exercise SARS-CoV-2 secondary outcome spirometry Symptom syndrome therapy Two-arm usual care West
[DOI] 10.1186/s13063-022-06632-y PMC 바로가기 [Article Type] Randomized Controlled Trial

Electronic field effect detection of SARS-CoV-2 N-protein before the onset of symptoms

증상 발현 전 SARS-CoV-2 N-단백질의 전자장 효과 검출

Article

Published on 2022-08-152022-09-11
Journal: Biosensors & bioelectronics [Category] COVID19(2023년), SARS, 치료기술, 치료법,

Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019

2019년 코로나바이러스 질환이 있는 멕시코 어린이 및 청소년의 임상 특징 및 중증 급성 호흡기 증후군-코로나바이러스-2 구조 단백질 기반 혈청학

Article

Published on 2022-08-152022-09-12
Journal: PLoS ONE [Category] SARS, 진단,

Host and microbiome features of secondary infections in lethal covid-19

Research article

Published on 2022-08-132022-10-05
Journal: iScience [Category] 바이오마커, 변종, 유전자 메커니즘, 진단, 치료기술,